Rapid Response of Myasthenic Ocular Signs to IvIg Treatment

KURNE A., ARSAVA E. M., DALKARA T.

NEURO-OPHTHALMOLOGY, vol.32, no.5, pp.249-252, 2008 (SCI-Expanded) identifier identifier

  • Publication Type: Article / Article
  • Volume: 32 Issue: 5
  • Publication Date: 2008
  • Doi Number: 10.1080/01658100802331653
  • Journal Name: NEURO-OPHTHALMOLOGY
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.249-252
  • Hacettepe University Affiliated: Yes

Abstract

Ocular symptoms of patients with myasthenia gravis respond to anticholinesterases favorably but usually incompletely. Here, we report 7 myasthenic patients whose ocular signs rapidly responded to intravenous immunoglobulin (IvIg) therapy. We propose that the IvIg should be considered in myasthenic patients whose ocular findings do not respond to conventional therapies. Future studies may disclose whether all patients with ocular involvement or only a subset of patients considerably respond to the IvIg.